Proton pump inhibitors therapy and risk of hyperprolactinemia with associated sexual disorders
, e
30 apr 2022
INFORMAZIONI SU QUESTO ARTICOLO
Pubblicato online: 30 apr 2022
Pagine: 134 - 147
DOI: https://doi.org/10.2478/enr-2022-0015
Parole chiave
© 2022 Muhammad Ashfaq et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Ashfaq, Muhammad
Department of Pharmacy, COMSATS University IslamabadAbbottabad Campus, Pakistan
Haroon, Muhammad Zeeshan
Department of Community Medicine, Ayub Medical CollegeAbbottabad, Pakistan
Alkahraman, Yasser MSA
Department of Pharmacy, COMSATS University IslamabadAbbottabad Campus, Pakistan